Development and validation of HPLC methods for enantioseparation of mirtazapine enantiomers at analytical and semipreparative scale using polysaccharide chiral stationary phases

Novel HPLC methods were developed for the analytical and semipreparative resolution of new antidepressant drug mirtazapine enantiomers. At analytical scale, the separation of the mirtazapine enantiomers was investigated using both cellulose and amylose tris(3,5-dimethylphenylcarbamate) (CDMPC and ADMPC) chiral stationary phases under normal-phases and polar organic modes. Good baseline enantioseparation was achieved using cellulose tris(3,5-dimethylphenylcarbamate) chiral stationary phases under both normal-phases and polar organic modes. Furthermore, the elution order of mirtazapine enantiomic pairs was found reversed by changing the stationary phase from the amylose-based ADMPC–CSPs to its cellulose-based counterpart, CDMPC–CSPs. The validation of the analytical methods including linearity, limit of detection (LOD), limit of quantification (LOQ), recovery and precision, together with the semipreparative resolution of mirtazapine racemate were carried out using cellulose tris(3,5-dimethylphenylcarbamate) chiral stationary phases and methanol as mobile phase without any basic additives under polar organic mode. At analytical scale, the elution times of both enantiomers were less than 6 min at normal temperature and 1.0 ml/min, with the separation factor () 1.99 and the resolution factor (Rs) 3.56. Then, the analytical methods were scaled up to semipreparative loading to obtain small quantities of both mirtazapine enantiomers. At semipreparative scale, about 16 mg/h enantiomers could be isolated and elution times of both enantiomers were less than 10 min at 2.0 ml/min. To increase the throughput, the technique of boxcar injections was used. One enantiomer ((−)-(R)-mirtazapine) was isolated with purity of >99.9% e.e. and >98.0% yield and another ((+)-(S)-mirtazapine) was isolated with purity of >97.0% e.e. and >99.0% yield. In addition, optical rotation and circular dichroism (CD) spectroscopy of both mirtazapine enantiomers isolated were also investigated.     

Self－assembly of Novel Hetero[3]rotaxane, [2]Rotaxanes and [2]Catenane

One linear template 13 and one cyclophane template 15, both incorporating two electron rich 1,4‐dialkoxybenzene units and one diamide unit, have been synthesized. By utilizing donor‐acceptor interaction and/or intermolecular hydrogen bonding assembling principles, one novel hetero[3]rotazane 22·4Cl, possessing one neutral and one tetracationic ring components, has been synthesized from 13, through neutral [2]rotaxane 21 as intermediate. With 15 as template, tetracationic [2]catenane 23·4PF₆ was assembled by using donor‐acceptor interaction, but no neutral [2]rotaxane could be obtained under the typical conditions of hydrogen bonding assembling principle. The interlocked supramolecular compounds have been characterized and their spectral properties are investigated.     

两个双核铁（Ⅲ）和三足配体的配合物的合成和晶体结构

运用三足四齿配体三（2－甲基吡啶）胺（TPA）或三（2－甲基苯丙咪唑）胺（TBA）,得到两个双核铁(III)配合物，[Fe₂L₂(μ₂-O)(μ₂-p-NH₂-C₆H₄COO)]³⁺ (L = TPA, 1 和 L = TBA, 2)。两个配合物均为单斜晶系，空间群为P2(1)/c.晶胞参数 1: a = 1.4529(4), b = 1.6622(5), c = 2.0625(6) nm, β= 100.327(5)º, V = 4.900(3) nm³, z = 4, F(000) = 2344, 分子量M_r = 1142.91, Dc = 1.549 g/cm³, R₁ = 0.0544, R₂ = 0.0962. 2: a = 1.3378(4), b = 2.1174(7), c = 2.4351(7) nm, β= 97.315(6)º, V = 6.842(4) nm³, z = 4, F (000) = 3116, 分子量M_r = 1505.08, Dc = 1.444 g/cm³, R₁ = 0.0793, R₂ = 0.1623. 在两个双核铁(III)配合物中，中心的三价铁和配体TPA或TBA上的四个氮原子和两个氧原子通过不同的桥形成一个畸变的八面体构型。     

Low-molecular-weight photoresponsive supramulecular hydrogel based on a dicationic azobenzene-bridged pyridinium hydrogelator

Photoresponsive supramolecular hydrogel was fabricated from a small azobenzene-bridged dicationic pyridinium salt in the aqueous solution. The UV-vis light triggered reversible gel-sol transformation of such low-molecular-weight supramolecular hydrogel was systematically investigated through various analytical techniques.     

Ce10Cl4Ga5 and Ln3ClGa4 (Ln = La,Ce): reduced halides or oxidized intermetallics?

The compounds Ce(10)Cl(4)Ga(5) and Ln(3)ClGa(4) (Ln = La, Ce) were synthesized from stoichiometric mixtures of Ln, LnCl(3), and Ga under Ar atmosphere in sealed Ta ampules at 910-1020 degrees C for 25-26 days. Ce(10)Cl(4)Ga(5) is isostructural to La(10)Cl(4)Ga(5) (space group I4/mcm, No. 140) with lattice constants a = 7.9546(11) A, c = 31.793(6) A. Ln(3)ClGa(4) represents a new structural type, also in the space group I4/mcm, with a = 8.1955(8) and 8.1123(11) A, c = 11.363(2) and 11.229(2) A, respectively, for Ln = La and Ce. Ce(10)Cl(4)Ga(5) features building blocks of Ga-centered Ce(6) trigonal prisms and distinctive two-dimensional intermetallic CuAl(2) and U(3)Si(2) type nets. Its electronic structure falls within the realm of reduced rare-earth halides. Ln(3)ClGa(4) also contains the intermetallic CuAl(2) type nets, but the interstitials are inverted: The building blocks are Cl-centered Ln(6) octahedra. Its electronic structure is characterized by strong peripheral Ln-Ga bonding stabilizing the Ln(6)Cl octahedron which normally would have its Ln-Ln antibonding orbitals filled with electrons from interstitials beyond chalcogen. Magnetic susceptibility and conductivity measurements confirm the metallic nature of all three compounds.     

酰氨基硫脲及其相关杂环衍生物的研究——ⅩⅤ.3-[5-(3-吡啶)-四唑-2-亚甲基]-4-芳基-1,2,4-三唑-5-烃硫醚类化合物的合成及其抗菌活性

以3-〔5-(-3吡啶)-四唑-2-亚甲基〕-4-芳基-1,2,4-三唑-5-硫酮为原料合成了19个3-〔5-(3-吡啶)-四唑-2-亚甲基〕4-芳基-1,2,4-三唑-5-烃硫醚类合化物,经元素分析、红外、核磁以及质谱确定了其结构,观察了化合物对枯草芽抱杆菌、大肠杆菌、变形杆菌以及金黄色葡萄菌的抑制,其中以化合物3_(α-k)的抑制活性最强。     

Polyoxometalate Derivatives with Multiple Organic Groups. 2. Synthesis and Structures of Tris(organotin) alpha, beta-Keggin Tungstosilicates

Eight tris(organotin)-substituted Keggin tungstosilicate heteropolyanions have been synthesized and characterized by elemental analysis, infrared and M?ssbauer spectroscopy, multinuclear NMR, and X-ray crystallography. The new anions contain alpha- or beta-SiW(9)O(34)(10)(-) moieties and are of two structural types, [(RSn)(3)(SiW(9)O(37))](7)(-) (R, isomer: Ph, alpha-, 1; n-Bu, alpha-, 2; Ph, beta-, 3; n-Bu, beta-, 4) and [(RSnOH)(3)(SiW(9)O(34))(2)](14)(-) (Ph, alpha-, 5; n-Bu, alpha-, 6; Ph, beta-, 7; n-Bu, beta-, 8). Crystals of Cs(4)H(3)[(PhSn)(3)(SiW(9)O(37))].8H(2)O (anion 3) are monoclinic, space group C2/c, with lattice constants a = 48.91(2) ?, b = 12.111(3) ?, c = 20.334(9) ?, beta = 102.30 degrees, and Z = 8. The anion has nominal C(3)(v)() symmetry and has a structure with three corner-shared WO(6) octahedra of the beta-Keggin anion replaced by three PhSnO(5) groups. Crystals of Cs(9)H(5)[(BuSnOH)(3)(SiW(9)O(34))(2)].36H(2)O (anion 6) are tetragonal, space group P&fourmacr;2(1)m, with lattice constants a = b = 29.005(4) ?, c = 13.412(4) ?, and Z = 4. The anion has the anticipated D(3)(h)() symmetry and contains three BuSnOH groups sandwiched between A,alpha-SiW(9)O(34)(10)(-) anions.     

Studies On Rare-Earth Complexes with Crown Ethers. Part XXV. Synthesis,characterization, and structure of the complexes of lanthanide nitrates with 13-crown-4

The lanthanide nitrate complexes with 13-crown-4(13-C-4) have been prepared in AcOEt. These new complexes with the general formula Ln(NO₃)₃.(13-c-4) (Ln = La–Nd, Sm–Lu) have been characterized by means of elemental analysis, IR and ¹H-NMR spectra, conductivity measurements, and TG-DTA techniques. The crystal and molecular structure of Nd(No₃)₃. (13-c-4) has been determined by single crystal X-ray diffraction. It crystallizes in the monoclinic space group P2₁/a with Z = 8. Lattice parameters are a = 15.393(1), b = 12.578(1), c = 19.279(2) Å, β = 113.05(1)°, V = 3435 ų, D_c = 2.01 g cm^?3, μ = 31.0 cm^?1 (Mok₂), F(000) = 2056. The structure was solved by Patterson and Fourier techniques and refined by least-squares to a final conventional R value of 0.032 for 5218 independent reflections with I ? 3σ(I). There are two independent Nd(No₃)₃ · (13-C-4) monomers in one asymmetrical unit. The coordination numbers are ten in these two independent monomers.     

On the Bose-Einstein condensation of free relativistic bosons with or without mass

The Bose-Einstein condensation of free relativistic particles [=(M ² c ⁴ +c ² p ² ) ^1/2 –Mc ² ] is studied rigorously. For massless bosons (=cp), the condensation transition of third (second) order occurs in2 (3) dimensions (D). The molar heat capacity follows the T ² (T ³ ) law below the condensation temperature T_c [k ^B T_c=(2 ² c ² n/1.645) ^1/2 [( ^{2 3} c ³ n/1.202) ^1/3 ], reaches4.38 (10.8) R at T=T_c, and approaches the high-temperature-limit value2 (3) R with no jump (a jump equal to6.75R) in2 (3)D. For finite-mass (M) bosons, the phase transition occurs only in3D with the condensation temperature T_c always smaller than that of the corresponding nonrelativistic bosons [=(2M) ^–1 p ² ]. If the mass M is reduced to zero, the condensation temperature T_c grows monotonically and reaches eventually that of massless relativistic bosons. This mass-dependence of T_c is therefore distinct from the case of nonrelativistic bosons, where T_c grows to infinity as M 0. A brief discussion is given for a possible connection with the normal-to-super transition of the independently moving Cooper pairs (bosons).